Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918185 · ClinicalTrials.gov registry record
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 56
- Enrollment target
NCT05918185: Completed study, sponsored by Mayo Clinic.
NCT05918185 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05918185 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
This study evaluates the association between a comprehensive geriatric assessment and laboratory biomarkers with the side effects of chemotherapy in older patients with multiple myeloma (MM). The comprehensive geriatric assessment is a tool that can help to determine how fit a patient is. It is composed of a series of questions and tests designed for older people to evaluate their physical function, mental status, mental health, nutritional status, social support, level of social activity, and the presence of other medical problems. In addition to geriatric assessment domains, laboratory biomarkers may provide information on physiologic dysfunction as a measure for evaluation of frailty in the cancer setting. This study will help researchers in the future by predicting which patients will have more side effects with chemotherapy based on their comprehensive geriatric assessment and laboratory biomarkers, which will allow adjustments to treatment in older adult patients with MM.
Primary Outcome
Will graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The maximum observed grade per adverse event and capture grade \>= 3 toxicities.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- OTHER Comprehensive Geriatric Assessment
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-02-15 |
| Est. Completion | 2025-08-30 |
What the finished NCT05918185 record still lists
NCT05918185 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT05918185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05918185 about?
NCT05918185 is a clinical study titled "Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma". This study evaluates the association between a comprehensive geriatric assessment and laboratory biomarkers with the side effects of chemotherapy in older patients with multiple myeloma (MM). The comprehensive geriatric assessment is a tool that can help to determine how fit a patient is. It is comp...
What is the current status of trial NCT05918185?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2023-02-15. Estimated completion is 2025-08-30.
What interventions are being tested in trial NCT05918185?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Comprehensive Geriatric Assessment (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05918185?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI